Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for BNKK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.10M
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 14.74M
June 30, 2025 1.671M
March 31, 2025 4.972M
December 31, 2024 0.7876M
September 30, 2024 4.209M
June 30, 2024 6.819M
March 31, 2024 3.792M
December 31, 2023 6.670M
September 30, 2023 2.679M
June 30, 2023 0.2997M
March 31, 2023 3.151M
December 31, 2022 -0.0091M
Date Value
September 30, 2022 -0.1757M
June 30, 2022 1.164M
March 31, 2022 -1.935M
December 31, 2021 0.0708M
September 30, 2021 25.17M
June 30, 2021 2.968M
March 31, 2021 0.00
December 31, 2020 5.505M
September 30, 2020 0.295M
June 30, 2020 0.3346M
March 31, 2020 0.575M
December 31, 2019 0.341M
September 30, 2019 0.6462M
June 30, 2019 0.0252M
March 31, 2019 0.05M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. 0.0209M
Skinhealth Systems, Inc. -0.224M
Evercore Holdings, Inc. 0.0219M
DND Technologies, Inc. --
CCA Industries, Inc. -0.2865M